Additional file 1 of Drug resistance in ovarian cancer: from mechanism to clinical trial

Additional file 1: Figure S1/S2. The summary of flow charts of clinical trials in I/II phase. The components in these flow chart include inclusion criteria, sample size, study duration, study arms, and study endpoints of these I-phase clinical trials about resistant ovarian cancer.

补充材料1：图S1/S2。该部分为I/II期临床试验流程图的汇总内容，其中涵盖了针对耐药性卵巢癌 (resistant ovarian cancer) 的I期临床试验的各项构成要素，具体包括纳入标准 (inclusion criteria)、样本量 (sample size)、研究周期 (study duration)、研究分组 (study arms) 以及研究终点 (study endpoints)。